LB Pharmaceuticals Inc Common Stock
LBRXNASDAQHealthcare● Active
$29.40
+$0.87(+3.05%)
Market Cap$843093569
P/E Ratio—
52W High$33.47
52W Low$13.36
LB Pharmaceuticals Inc Common Stock（LBRX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LBRX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($0.03B) | ($0.06B) | ($0.01B) | ($0.01B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.01B) | $0.00B | ($0.00B) | $0.00B |
| Net Cash from Operations | ($0.04B) | ($0.05B) | ($0.01B) | ($0.00B) |
| Investing Activities | ||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B |
| Purchases of Investments | ($0.04B) | ($0.03B) | ($0.03B) | $0.00B |
| Sales of Investments | $0.01B | $0.05B | $0.01B | $0.00B |
| Net Cash from Investing | ($0.04B) | $0.02B | ($0.03B) | $0.00B |
| Financing Activities | ||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.03B |
| Net Cash from Financing | $0.30B | $0.04B | $0.03B | $0.02B |
| Free Cash Flow | ||||
| Free Cash Flow | ($0.04B) | ($0.05B) | ($0.01B) | ($0.00B) |
| FCF Margin %(computed) | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解LB Pharmaceuticals Inc Common Stock
关于LB Pharmaceuticals Inc Common Stock（LBRX）现金流量表
LB Pharmaceuticals Inc Common Stock 2025财年经营活动现金流($0.04B)，自由现金流($0.04B)（FCF利润率—），资本支出($0.00B)。
常见问题
LBRX · 4 问LB Pharmaceuticals Inc Common Stock 2025财年自由现金流($0.04B)，同比up34.5%。
LBRX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10